Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, SKAN Group AG's Enterprise Value is CHF1,309.6 Mil.
SKAN Group AG's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was CHF18.2 Mil. Therefore, SKAN Group AG's EV-to-FCF for today is 71.79.
The historical rank and industry rank for SKAN Group AG's EV-to-FCF or its related term are showing as below:
CHIX:SKANz'
s EV-to-FCF Range Over the Past 10 Years
Min: -245.53 Med: -22.88 Max: 78.45
Current: 72.16
During the past 6 years, the highest EV-to-FCF of SKAN Group AG was 78.45. The lowest was -245.53. And the median was -22.88.
CHIX:SKANz's EV-to-FCF is ranked worse than 82.61% of 414
companies
in the Medical Devices & Instruments industry
Industry Median: 23.21
vs CHIX:SKANz: 72.16
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
SKAN Group AG's PE Ratio (TTM) for today is calculated as:
SKAN Group AG's share price for today is CHF55.75.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. SKAN Group AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was CHF0.720.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
SKAN Group AG EV-to-FCF Related Terms
SKAN Group AG EV-to-FCF Historical Data
* Premium members only.
The historical data trend for SKAN Group AG's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CHIX:SKANZ vs ISRG, BDX, MDLN: EV-to-FCF Comparison
For the Medical Instruments & Supplies subindustry, SKAN Group AG's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SKAN Group AG EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, SKAN Group AG's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where SKAN Group AG's EV-to-FCF falls into.
SKAN Group AG's current Enterprise Value is CHF1,309.6 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. SKAN Group AG's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was CHF18.2 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SKAN Group AG (CHIX:SKANZ) has a EV-to-FCF of 71.79 as of Jul. 21, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on SKAN Group AG and its competitors. According to the industry distribution chart, SKAN Group AG ranks #342 out of 414 companies in the Medical Devices & Instruments industry, placing it in the top 82.6%.
Is SKAN Group AG's EV-to-FCF too high?
SKAN Group AG's current EV-to-FCF is 71.79. The Medical Devices & Instruments industry median EV-to-FCF is 23.21. SKAN Group AG's value of 71.79 is 209.3% above this industry median. Based on the distribution chart, SKAN Group AG ranks #342 out of 414 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, SKAN Group AG has a GF Score™ of 81/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does SKAN Group AG's EV-to-FCF compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, SKAN Group AG ranks #342 out of 414 companies for EV-to-FCF. This places SKAN Group AG in the lower half of its industry. The industry median EV-to-FCF is 23.21. SKAN Group AG's value of 71.79 is 209.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 23.21, based on 414 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SKAN Group AG's current EV-to-FCF of 71.79 is 209.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on SKAN Group AG and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 23.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SKAN Group AG's current EV-to-FCF is 71.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SKAN Group AG stock overvalued right now?
Based on GuruFocus' analysis, SKAN Group AG (CHIX:SKANZ) is currently considered Significantly Undervalued. The stock's GF Value™ is CHF86.40, compared to a current price of CHF55.75 — trading 35.5% below its estimated fair value. The current EV-to-FCF is 71.79 and 209.3% above the Medical Devices & Instruments industry median of 23.21. SKAN Group AG's overall GF Score™ is 81/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For SKAN Group AG (CHIX:SKANZ), the current EV-to-FCF is 71.79 as of Jul. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SKAN Group AG (CHIX:SKANZ) Overvalued in 2026?
Based on GuruFocus' analysis, SKAN Group AG stock appears to be undervalued.
The current stock price of CHF55.75 is trading 35.5% below its estimated GF Value™ of CHF86.40.
GuruFocus considers SKAN Group AG to be Significantly Undervalued.
Key valuation signals for CHIX:SKANZ:
EV-to-FCF: 71.79
GF Value™: CHF86.40 vs. price of CHF55.75 (35.5% below fair value)
Industry Position: 209.3% above the Medical Devices & Instruments median (#342 of 414)
No single metric tells the full story. See the CHIX:SKANZ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SKAN Group AG is a market and technological company for isolators, cleanroom devices, and decontamination processes for the aseptic production of biopharmaceutical substances. The company offers its customers process support, services, and consumables. Its products include biological indicators, isolators, Laboratory/cleanroom equipment, laminar flow, safety workbenches, transfer systems, and others. The Firm has three operating segments: Equipment & solutions, Services & Consumables, and Other. The company generates the majority of its revenue from the Equipment & solutions segment. Geographically, the company derives revenue from Asia, Europe, Americas, and Other regions.
81GF Score
Get the complete analysis for CHIX:SKANZ
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:SKANZ has been successfully added to your 
